[Federal Register Volume 88, Number 208 (Monday, October 30, 2023)]
[Notices]
[Page 74198]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-23881]



[[Page 74198]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Board of Scientific 
Counselors, National Cancer Institute.
    The meeting will be held as a virtual meeting and is open to the 
public as indicated below. Individuals who plan to view the virtual 
meeting and need special assistance or other reasonable accommodations 
to view the meeting, should notify the Contact Person listed below in 
advance of the meeting. The open session will be videocast and can be 
accessed from the NIH Videocast at the following link: http://videocast.nih.gov/.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in section 552b(c)(6), title 5 
U.S.C., as amended for the review, discussion, and evaluation of 
individual intramural programs and projects conducted by the National 
Cancer Institute, including consideration of personnel qualifications 
and performance, and the competence of individual investigators, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: Board of Scientific Counselors, National 
Cancer Institute.
    Date: March 4, 2024.
    Open: 11:00 a.m. to 11:30 a.m.
    Agenda: Remarks from the NCI Director.
    Closed: 11:40 a.m. to 4:30 p.m.
    Agenda: Personnel qualifications and performance, and competence 
of individual investigators.

    Name of Committee: Board of Scientific Counselors, National 
Cancer Institute.
    Date: March 5, 2024.
    Closed: 11:00 a.m. to 1:30 p.m.
    Agenda: Personnel qualifications and performance, and competence 
of individual investigators.
    Place: National Cancer Institute, 9609 Medical Center Drive, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Brian E. Wojcik, Ph.D., Senior Review 
Administrator, Institute Review Office, Office of the Director, 
National Cancer Institute, National Institutes of Health, 9609 
Medical Center Drive, Room 3W414, Rockville, MD 20850, 240-276-5660, 
[email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: https://deainfo.nci.nih.gov/advisory/bsc/index.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: October 25, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-23881 Filed 10-27-23; 8:45 am]
BILLING CODE 4140-01-P